ATE258166T1 - Substituierte benzylaminpiperidin-verbindungen - Google Patents

Substituierte benzylaminpiperidin-verbindungen

Info

Publication number: ATE258166T1
Authority: AT; Austria
Prior art keywords: benzylaminpiperidine; substituted; compounds; substituted benzylaminpiperidine; benzylaminpiperidine compounds
Prior art date: 1995-08-24

Application number

AT01108350T

Other languages

English (en)

Inventor

Kunio Satake

Yuji Shishido

Hiroaki Wakabayashi

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-24

Filing date

1996-06-10

Publication date

2004-02-15

1996-06-10 Application filed by Pfizer filed Critical Pfizer

2004-02-15 Application granted granted Critical

2004-02-15 Publication of ATE258166T1 publication Critical patent/ATE258166T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01108350T 1995-08-24 1996-06-10 Substituierte benzylaminpiperidin-verbindungen ATE258166T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IB9500683		1995-08-24

Publications (1)

Publication Number	Publication Date
ATE258166T1 true ATE258166T1 (de)	2004-02-15

Family

ID=11004362

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT01108350T ATE258166T1 (de)	1995-08-24	1996-06-10	Substituierte benzylaminpiperidin-verbindungen
AT96914375T ATE208377T1 (de)	1995-08-24	1996-06-10	Substituierte benzylaminopiperloin verbindungen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT96914375T ATE208377T1 (de)	1995-08-24	1996-06-10	Substituierte benzylaminopiperloin verbindungen

Country Status (41)

Country	Link
US (1)	US6506775B1 (de)
EP (2)	EP0861235B1 (de)
JP (1)	JP3084069B2 (de)
KR (1)	KR100288673B1 (de)
CN (1)	CN1153764C (de)
AP (1)	AP643A (de)
AR (1)	AR006305A1 (de)
AT (2)	ATE258166T1 (de)
AU (1)	AU702698B2 (de)
BG (1)	BG64126B1 (de)
BR (1)	BR9609989A (de)
CA (1)	CA2227814C (de)
CO (1)	CO4480738A1 (de)
CZ (1)	CZ297543B6 (de)
DE (2)	DE69631390T2 (de)
DK (2)	DK1114817T3 (de)
DZ (1)	DZ2086A1 (de)
ES (2)	ES2163017T3 (de)
HR (1)	HRP960386B1 (de)
HU (1)	HU225480B1 (de)
IL (1)	IL119078A (de)
IS (1)	IS1947B (de)
MA (1)	MA23961A1 (de)
MX (1)	MX9801467A (de)
MY (1)	MY114800A (de)
NO (1)	NO310720B1 (de)
NZ (1)	NZ308207A (de)
OA (1)	OA10666A (de)
PE (2)	PE1398A1 (de)
PL (1)	PL186773B1 (de)
PT (2)	PT861235E (de)
RO (1)	RO119299B1 (de)
RU (1)	RU2152930C2 (de)
SI (2)	SI0861235T1 (de)
SK (1)	SK282925B6 (de)
TN (1)	TNSN96107A1 (de)
TR (1)	TR199800300T1 (de)
TW (1)	TW340842B (de)
UA (1)	UA48981C2 (de)
WO (1)	WO1997008144A1 (de)
YU (1)	YU49122B (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9706196A (es) *	1996-08-14	1998-02-28	Pfizer	Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p.
TW426667B (en) *	1997-11-19	2001-03-21	Pfizer	Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
US6777428B1 (en)	1999-02-10	2004-08-17	Eli Lilly And Company	5-HT1f agonist
IL145945A0 (en) *	1999-05-06	2002-07-25	Pfizer Prod Inc	Substituted benzolactam compounds
RS49964B (sr)	1999-05-17	2008-09-29	Pfizer Products Inc.,	Postupak za dobijanje 2-fenil-3-aminopiridina,njegovih supstituisanih fenil derivata, i njegovih soli
CA2374643C (en) *	1999-05-21	2006-02-14	Pfizer Products Inc.	1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists
DK1095939T3 (da) *	1999-10-18	2004-04-13	Pfizer Prod Inc	Fremgangsmåde til fremstilling af cykliske piperidinylaminomethyltrifluormethyletherforbindelser
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
KR100885986B1 (ko)	1999-11-03	2009-03-03	에이엠알 테크놀로지, 인크.	노르에피네프린, 도파민 및 세로토닌의 재흡수를 방지하기위한 아릴 및 헤테로아릴 치환된테트라하이드로이소퀴놀린 및 이들의 용도
KR100821410B1 (ko)	2000-07-11	2008-04-10	에이엠알 테크놀로지, 인크.	4-페닐 치환된 테트라하이드로이소퀴놀린 및 이의치료학적 용도
PA8525601A1 (es) *	2000-08-21	2002-04-25	Hoffmann La Roche	Profarmacos de (3s,4s)-4-bencil-1-[2-(4-hidroxi-bencenosulfonil)-etil]-piperidin-3-ol
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (de) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst
US6911544B2 (en)	2002-10-23	2005-06-28	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-phenyl-3-aminopiperidine
ES2388547T3 (es)	2003-04-18	2012-10-16	Eli Lilly And Company	Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas de 5-HT 1F
CA2566920A1 (en) *	2004-05-21	2005-12-01	Pfizer Products Inc.	Metabolites of (+)-(2s, 3s)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenyl-piperidine
AU2005274927B2 (en)	2004-07-15	2011-11-03	Albany Molecular Research, Inc.	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
ES2382814T3 (es)	2005-05-17	2012-06-13	Merck Sharp & Dohme Ltd.	Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
US7956050B2 (en)	2005-07-15	2011-06-07	Albany Molecular Research, Inc.	Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
AU2006297443B2 (en)	2005-09-29	2010-08-12	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
SE529246C2 (sv) *	2005-10-13	2007-06-12	Neurosearch Sweden Ab	Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
AU2007300627B2 (en)	2006-09-22	2012-02-16	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
EP2805945B1 (de)	2007-01-10	2019-04-03	MSD Italia S.r.l.	Amidsubstituierte Indazole als Poly-(ADP-Ribose)-Polymerase (PARP)-Hemmer
JP5319518B2 (ja)	2007-04-02	2013-10-16	Ｍｓｄ株式会社	インドールジオン誘導体
EP3103791B1 (de)	2007-06-27	2018-01-31	Merck Sharp & Dohme Corp.	4-carboxybenzylamino-derivate als histondeacetylase-hemmer
EP2247185B1 (de)	2008-03-03	2014-04-16	Tiger Pharmatech	Tyrosinkinase-hemmer
EP2264029A4 (de)	2008-03-31	2011-08-24	Kowa Co	1,3-dihydroisobenzofuran-derivat
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
US9034899B2 (en)	2009-05-12	2015-05-19	Albany Molecular Research, Inc.	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
JP5739415B2 (ja)	2009-05-12	2015-06-24	ブリストル−マイヤーズスクウィブカンパニー	（Ｓ）−７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンの結晶形態およびその使用
JP5764553B2 (ja)	2009-05-12	2015-08-19	アルバニーモレキュラーリサーチ，インコーポレイテッド	７−（［１，２，４］トリアゾロ［１，５−ａ］ピリジン−６−イル）−４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロイソキノリンおよびその使用
AU2010307198B9 (en)	2009-10-14	2014-02-13	Merck Sharp & Dohme Corp.	Substituted piperidines that increase p53 activity and the uses thereof
US8999957B2 (en)	2010-06-24	2015-04-07	Merck Sharp & Dohme Corp.	Heterocyclic compounds as ERK inhibitors
EP2601293B1 (de)	2010-08-02	2017-12-06	Sirna Therapeutics, Inc.	Rna-interferenz-vermittelte hemmung der catenin (cadherin-assoziiertes protein)-beta-1 (ctnnb1)- genexpression mittels kurzer interferierender nukleinsäuren (sina)
CN103282497B (zh)	2010-08-17	2018-07-10	瑟纳治疗公司	使用短干扰核酸(siNA)的乙型肝炎病毒(HBV)基因表达的RNA干扰介导的抑制
WO2012027236A1 (en)	2010-08-23	2012-03-01	Schering Corporation	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
EP2613782B1 (de)	2010-09-01	2016-11-02	Merck Sharp & Dohme Corp.	Indazolderivate als erk-hemmer
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
ES2663009T3 (es)	2010-10-29	2018-04-10	Sirna Therapeutics, Inc.	Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic)
EP2654748B1 (de)	2010-12-21	2016-07-27	Merck Sharp & Dohme Corp.	Indazolderivate als erk-hemmer
WO2012143879A1 (en)	2011-04-21	2012-10-26	Piramal Healthcare Limited	A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
WO2013063214A1 (en)	2011-10-27	2013-05-02	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
EP2844261B1 (de)	2012-05-02	2018-10-17	Sirna Therapeutics, Inc.	Sina-zusammensetzungen
AU2013323508B2 (en)	2012-09-28	2017-11-02	Merck Sharp & Dohme Corp.	Novel compounds that are ERK inhibitors
JP6440625B2 (ja)	2012-11-14	2018-12-19	ザ・ジョンズ・ホプキンス・ユニバーシティー	精神分裂病を処置するための方法および組成物
JP6290237B2 (ja)	2012-11-28	2018-03-07	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	癌を処置するための組成物および方法
WO2014100065A1 (en)	2012-12-20	2014-06-26	Merck Sharp & Dohme Corp.	Substituted imidazopyridines as hdm2 inhibitors
EP2951180B1 (de)	2013-01-30	2018-05-02	Merck Sharp & Dohme Corp.	2,6,7,8-substituierte purine als hdm2-inhibitoren
EP3041938A1 (de)	2013-09-03	2016-07-13	Moderna Therapeutics, Inc.	Kreisförmige polynukleotide
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
WO2019094311A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
WO2019094312A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
US11993602B2 (en)	2018-08-07	2024-05-28	Merck Sharp & Dohme Llc	PRMT5 inhibitors
KR20210046009A (ko)	2018-08-07	2021-04-27	머크 샤프 앤드 돔 코포레이션	Prmt5 억제제
US11981701B2 (en)	2018-08-07	2024-05-14	Merck Sharp & Dohme Llc	PRMT5 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5232929A (en) *	1990-11-28	1993-08-03	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
US5364943A (en) *	1991-11-27	1994-11-15	Pfizer Inc.	Preparation of substituted piperidines
RU2105001C1 (ru) *	1991-03-26	1998-02-20	Пфайзер Инк.	Способ получения замещенных 3-аминопиперидинов
RU2114848C1 (ru) *	1991-06-20	1998-07-10	Пфайзер Инк.	Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ ингибирования действия вещества р у млекопитающих
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (de) *	1993-11-17	1995-10-11	Pfizer	Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes.
EP0655246A1 (de) *	1993-11-30	1995-05-31	Pfizer Inc.	Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten
JP3992733B2 (ja)	1995-03-27	2007-10-17	久光製薬株式会社	ピペリジン誘導体
ATE223896T1 (de) *	1995-12-21	2002-09-15	Pfizer	3-((5-substituierte benzyl)amino)-2- phenylpiperidine als substance-p-antagonisten
US5990125A (en)	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer

1996
- 1996-06-04 TW TW085106675A patent/TW340842B/zh active
- 1996-06-10 EP EP96914375A patent/EP0861235B1/de not_active Expired - Lifetime
- 1996-06-10 TR TR1998/00300T patent/TR199800300T1/xx unknown
- 1996-06-10 CN CNB961965037A patent/CN1153764C/zh not_active Expired - Fee Related
- 1996-06-10 BR BR9609989A patent/BR9609989A/pt not_active Application Discontinuation
- 1996-06-10 DK DK01108350T patent/DK1114817T3/da active
- 1996-06-10 PT PT96914375T patent/PT861235E/pt unknown
- 1996-06-10 AT AT01108350T patent/ATE258166T1/de not_active IP Right Cessation
- 1996-06-10 HU HU9901159A patent/HU225480B1/hu not_active IP Right Cessation
- 1996-06-10 MX MX9801467A patent/MX9801467A/es active IP Right Grant
- 1996-06-10 CA CA002227814A patent/CA2227814C/en not_active Expired - Fee Related
- 1996-06-10 AU AU57769/96A patent/AU702698B2/en not_active Ceased
- 1996-06-10 DE DE69631390T patent/DE69631390T2/de not_active Expired - Fee Related
- 1996-06-10 WO PCT/IB1996/000572 patent/WO1997008144A1/en not_active Ceased
- 1996-06-10 PT PT01108350T patent/PT1114817E/pt unknown
- 1996-06-10 SI SI9630374T patent/SI0861235T1/xx unknown
- 1996-06-10 UA UA98020924A patent/UA48981C2/uk unknown
- 1996-06-10 TN TNTNSN96107A patent/TNSN96107A1/fr unknown
- 1996-06-10 PL PL96325332A patent/PL186773B1/pl not_active IP Right Cessation
- 1996-06-10 RU RU98102959/04A patent/RU2152930C2/ru not_active IP Right Cessation
- 1996-06-10 KR KR1019980701310A patent/KR100288673B1/ko not_active Expired - Fee Related
- 1996-06-10 DE DE69616817T patent/DE69616817T2/de not_active Expired - Fee Related
- 1996-06-10 CZ CZ0052198A patent/CZ297543B6/cs not_active IP Right Cessation
- 1996-06-10 RO RO98-00334A patent/RO119299B1/ro unknown
- 1996-06-10 NZ NZ308207A patent/NZ308207A/en unknown
- 1996-06-10 SK SK207-98A patent/SK282925B6/sk not_active IP Right Cessation
- 1996-06-10 ES ES96914375T patent/ES2163017T3/es not_active Expired - Lifetime
- 1996-06-10 SI SI9630670T patent/SI1114817T1/xx unknown
- 1996-06-10 JP JP09510015A patent/JP3084069B2/ja not_active Expired - Fee Related
- 1996-06-10 ES ES01108350T patent/ES2211684T3/es not_active Expired - Lifetime
- 1996-06-10 DK DK96914375T patent/DK0861235T3/da active
- 1996-06-10 AT AT96914375T patent/ATE208377T1/de not_active IP Right Cessation
- 1996-06-10 EP EP01108350A patent/EP1114817B1/de not_active Expired - Lifetime
- 1996-08-15 IL IL11907896A patent/IL119078A/xx not_active IP Right Cessation
- 1996-08-20 AR ARP960104045A patent/AR006305A1/es active IP Right Grant
- 1996-08-21 PE PE1996000625A patent/PE1398A1/es not_active Application Discontinuation
- 1996-08-21 DZ DZ960130A patent/DZ2086A1/fr active
- 1996-08-21 PE PE2001000276A patent/PE20010700A1/es not_active Application Discontinuation
- 1996-08-22 HR HR960386A patent/HRP960386B1/xx not_active IP Right Cessation
- 1996-08-23 MA MA24339A patent/MA23961A1/fr unknown
- 1996-08-23 YU YU47896A patent/YU49122B/sh unknown
- 1996-08-23 MY MYPI96003496A patent/MY114800A/en unknown
- 1996-08-24 AP APAP/P/1996/000850A patent/AP643A/en active
- 1996-08-26 CO CO96045248A patent/CO4480738A1/es unknown
1997
- 1997-12-30 IS IS4644A patent/IS1947B/is unknown
1998
- 1998-02-23 NO NO19980751A patent/NO310720B1/no unknown
- 1998-02-23 OA OA9800023A patent/OA10666A/en unknown
- 1998-02-27 BG BG102288A patent/BG64126B1/bg unknown
2000
- 2000-05-01 US US09/564,398 patent/US6506775B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
SK282925B6 (sk)	2003-01-09
CZ52198A3 (cs)	1999-01-13
KR19990044077A (ko)	1999-06-25
JP3084069B2 (ja)	2000-09-04
DE69631390D1 (de)	2004-02-26
HU225480B1 (en)	2006-12-28
RU2152930C2 (ru)	2000-07-20
KR100288673B1 (ko)	2001-05-02
DE69616817D1 (de)	2001-12-13
IL119078A (en)	2003-11-23
SK20798A3 (en)	1999-03-12
PL325332A1 (en)	1998-07-20
DE69616817T2 (de)	2002-04-04
BG64126B1 (bg)	2004-01-30
MX9801467A (es)	1998-05-31
OA10666A (en)	2002-11-25
EP1114817B1 (de)	2004-01-21
DK0861235T3 (da)	2001-12-27
AP9600850A0 (en)	1996-10-31
IS4644A (is)	1997-12-30
HRP960386A2 (en)	1998-04-30
NO980751L (no)	1998-02-23
ES2211684T3 (es)	2004-07-16
HRP960386B1 (en)	2002-04-30
AU702698B2 (en)	1999-03-04
CA2227814A1 (en)	1997-03-06
SI0861235T1 (en)	2002-04-30
WO1997008144A1 (en)	1997-03-06
TW340842B (en)	1998-09-21
NZ308207A (en)	1998-07-28
YU47896A (sh)	1998-12-23
CN1153764C (zh)	2004-06-16
TR199800300T1 (xx)	1998-06-22
ATE208377T1 (de)	2001-11-15
CO4480738A1 (es)	1997-07-09
PE20010700A1 (es)	2001-07-09
DZ2086A1 (fr)	2002-07-22
HUP9901159A2 (hu)	1999-07-28
NO310720B1 (no)	2001-08-20
TNSN96107A1 (fr)	2005-03-15
HUP9901159A3 (en)	2000-05-29
CN1193961A (zh)	1998-09-23
BR9609989A (pt)	1999-07-06
DK1114817T3 (da)	2004-04-26
PT861235E (pt)	2002-03-28
IL119078A0 (en)	1996-11-14
JPH10510554A (ja)	1998-10-13
EP0861235B1 (de)	2001-11-07
RO119299B1 (ro)	2004-07-30
SI1114817T1 (en)	2004-06-30
IS1947B (is)	2004-10-13
HK1014935A1 (en)	1999-10-08
AR006305A1 (es)	1999-08-25
CZ297543B6 (cs)	2007-02-07
EP1114817A1 (de)	2001-07-11
PE1398A1 (es)	1998-02-27
ES2163017T3 (es)	2002-01-16
PL186773B1 (pl)	2004-02-27
EP0861235A1 (de)	1998-09-02
MA23961A1 (fr)	1997-04-01
UA48981C2 (uk)	2002-09-16
US6506775B1 (en)	2003-01-14
MY114800A (en)	2003-01-31
CA2227814C (en)	2002-12-31
AP643A (en)	1998-04-24
NO980751D0 (no)	1998-02-23
PT1114817E (pt)	2004-05-31
AU5776996A (en)	1997-03-19
BG102288A (en)	1998-09-30
DE69631390T2 (de)	2004-11-25
YU49122B (sh)	2004-03-12

Publication	Publication Date	Title
ATE258166T1 (de)	2004-02-15	Substituierte benzylaminpiperidin-verbindungen
ID16345A (id)	1997-09-25	Senyawa-senyawa heterosiklik
BR9607097A (pt)	1997-11-11	Novos compostos
FI960519L (fi)	1996-08-07	Uusia yhdisteitä
DE59609887D1 (de)	2003-01-02	Substituierte cyanophenyluracile
DK0777671T3 (da)	2000-07-24	Spiro-azabicykliske forbindelser
FI971260A7 (fi)	1997-03-26	1-asyyli-4-alifatyyliaminopiperidiiniyhdisteet
DE69608259D1 (de)	2000-06-15	Verbunddamenbinde
BR9600251A (pt)	1997-12-23	Composto
DE69630414D1 (de)	2003-11-27	5B4T-Kodierungsschema
ATA135896A (de)	2001-02-15	Skibob
IS4739A (is)	1998-05-12	Efnasambönd
NO974170D0 (no)	1997-09-09	Polyazacykloalkan-forbindelser
DE59610332D1 (de)	2003-05-15	Substituierte aminouracile
FI970151A0 (fi)	1997-01-14	Viruksenvastaisesti vaikuttavia difluoristatoniyhdisteitä
BR9601295A (pt)	1998-01-13	Composto
BR9609319A (pt)	1999-07-06	Carbonilaminofeniluracilas substituídas
BR9608890A (pt)	1999-06-15	N-metilenotiouréias substituídas
BR9611576A (pt)	1999-03-30	Composto
FI2049U1 (fi)	1995-08-03	Faestdon
BR9603376A (pt)	1998-05-12	Tetrahidro-5-nitro-pirimidinas substituídas
DE59607732D1 (de)	2001-10-25	Substituierte benzylidencyanessigester
FI971971A7 (fi)	1997-05-12	Pyridatsinokinoliiniyhdisteitä
ATE240972T1 (de)	2003-06-15	Cyclopeptolide
ID18956A (id)	1998-05-28	Senyawa-senyawa herbisida

Legal Events

Date	Code	Title	Description
2004-08-15	UEP	Publication of translation of european patent specification	Ref document number: 1114817 Country of ref document: EP
2010-03-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2004-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1114817

Country of ref document: EP

2010-03-15

REN

Ceased due to non-payment of the annual fee